Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.61 |
| ▸ | HLCS | P50747 | 3/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | ABL1 | P00519 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | IDE | P14735 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.59 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 4/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30800274 | 1.00 | TDP1 (0.61) | TDP1HLCSMEN1ABL1LMNA | |
| SCHEMBL5817718 | 0.98 | HLCS (0.63) | TDP1HLCSMEN1ABL1LMNA | |
| SCHEMBL5821183 | 0.97 | HLCS (0.64) | TDP1HLCSMEN1ABL1LMNA | |
| SCHEMBL515856 | 0.97 | HLCS (0.64) | TDP1HLCSMEN1ABL1LMNA | |
| SCHEMBL2456107 | 0.97 | HLCS (0.64) | TDP1HLCSMEN1ABL1LMNA | |
| SCHEMBL6159219 | 0.96 | HLCS (0.60) | TDP1HLCSMEN1ABL1LMNA | |
| SCHEMBL30337427 | 0.95 | HLCS (0.58) | TDP1HLCSMEN1ABL1LMNA | |
| SCHEMBL13034043 | 0.91 | HLCS (0.59) | TDP1HLCSMEN1ABL1LMNA | |
| SCHEMBL15353872 | 0.90 | TDP1 (0.64) | TDP1HLCSMEN1ABL1LMNA | |
| SCHEMBL739034 | 0.90 | TDP1 (0.63) | TDP1HLCSMEN1ABL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230391828-A1 | REGULATORS OF CELL DIVISION | TECHNISCHE UNIVERSITAT DRESDEN (DE) | 2023-12-07 | — | — | US | claimed |
| CN-111624351-B | Epitope identification method of bacterial antibody | 江苏海洋大学 | 2023-11-24 | — | — | CN | claimed |
| EP-4225780-A2 | REGULATORS OF CELL DIVISION | Technische Universität Dresden (DE) | 2023-08-16 | — | — | EP | claimed |
| EP-3996731-A1 | PEPTIDES AND METHODS FOR TREATING DISEASES | OP-T LLC (US) | 2022-05-18 | — | — | EP | claimed |
| WO-2022074072-A2 | REGULATORS OF CELL DIVISION | Technische Universität Dresden (DE) | 2022-04-14 | — | — | WO | claimed |
| EP-3981784-A1 | REGULATORS OF CELL DIVISION | Technische Universität Dresden (DE) | 2022-04-13 | — | — | EP | claimed |
| EP-4744724-A2 | PEPTIDES AND METHODS FOR TREATING DISEASES | OP-T LLC (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4729520-A1 | CONFORMATIONALLY FIXED DIPROLINE MIMETICS AND THEIR USE | Prosion GmbH (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4729523-A1 | BICYCLIC DIPEPTIDE MIMETICS AND THEIR USE | Prosion GmbH (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4726391-A1 | NOVEL CITRULLINATED PEPTIDES THAT BIND TO ANTI-CITRULLINATED PROTEIN ANTIBODIES (ACPAS) AND THEIR USE IN THE DIAGNOSIS AND PREDICTION OF RHEUMATOID ARTHRITIS | Vacara AB (SE) | 2026-04-15 | — | — | EP | disclosed |
| US-12600710-B2 | Beta-catenin and b-cell lymphoma 9 (BCL9) inhibitors | Lee Moffitt Cancer Center and Research Institute, Inc. (US) | 2026-04-14 | — | — | US | disclosed |
| US-20260085057-A1 | SUBSTITUTED INDAZOLES USEFUL FOR TREATMENT AND PREVENTION OF ALLERGIC AND/OR INFLAMMATORY DISEASES IN ANIMALS | Bayer Pharma AG (DE) | 2026-03-26 | — | — | US | disclosed |
| EP-4712998-A1 | DUAL-DOMAIN PEPTIDE FOR DEPLETING HMGB1 FROM THE CIRCULATION VIA LIVER HSPG SYSTEM | The Medical College of Wisconsin (US) | 2026-03-25 | — | — | EP | disclosed |
| CN-110305109-B | Novel substituted indazoles, method for the production thereof, pharmaceutical preparations containing same, and use thereof for producing medicaments | 拜耳医药股份有限公司 | 2022-04-08 | — | — | CN | disclosed |
| WO-2022067100-A2 | PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-03-31 | — | — | WO | disclosed |
| EP-3959212-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS | Bayer Aktiengesellschaft (DE) | 2022-03-02 | — | — | EP | disclosed |
| EP-3959211-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS | Bayer Aktiengesellschaft (DE) | 2022-03-02 | — | — | EP | disclosed |
| EP-3958865-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2022-03-02 | — | — | EP | disclosed |
| CN-114127064-A | 4H-pyrrolo [3,2-c ] pyridin-4-one compounds | 拜耳股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| WO-2006121234-A1 | BIOTIN-AMINO ACID CONJUGATE USEFUL AS A HYDROGELATOR AND HYDROGEL PREPARED THEREFROM | POSTECH FOUNDATION (KR) | 2006-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600710-B2 | Beta-catenin and b-cell lymphoma 9 (BCL9) inhibitors | BCL9, BCL9L, BCL3 | TDP1 4346/4885HLCS 887/4885MEN1 2873/4885 |
| US-20260085057-A1 | SUBSTITUTED INDAZOLES USEFUL FOR TREATMENT AND PREVENTION OF ALLERGIC AND/OR INFLAMMATORY DISEASES IN ANIMALS | HRH4, BRCA1, HRH1 | TDP1 3031/4885HLCS 1169/4885MEN1 2640/4885 |
| US-20230391828-A1 | REGULATORS OF CELL DIVISION | PCNA, BOD1L1, MKI67 | TDP1 1448/4885HLCS 1671/4885MEN1 1402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.